share_log

Bowlero, Harmonic And Some Other Big Stocks Moving Higher On Friday

Bowlero, Harmonic And Some Other Big Stocks Moving Higher On Friday

Bowlero、Harmonic和其他一些大型股票週五走高
Benzinga Real-time News ·  2022/09/16 10:44

U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Friday. Here are some big stocks recording gains in today's session.

美國股市走低，道瓊斯指數週五下跌約200點。以下是今日盤中錄得漲幅的一些大盤股。

  • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) shares jumped 22.2% to $2.5788 after dropping 38% on Thursday.
  • Bowlero Corp. (NYSE:BOWL) surged 8.1% to $13.48 after the company reported better-than-expected Q4 sales.
  • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 8.1% to $6.03.
  • Harmonic Inc. (NASDAQ:HLIT) rose 7.6% to $12.05. Needham maintained Harmonic with a Buy and raised the price target from $15 to $17.
  • AMTD Digital Inc. (NYSE:HKD) rose 7.1% to $144.28 after tumbling around 29% on Thursday.
  • Lucid Group, Inc. (NASDAQ:LCID) jumped 6.5% to $17.55.
  • Hudson Technologies, Inc. (NASDAQ:HDSN) gained 6.4% to $8.04. The company, last month, posted upbeat quarterly results.
  • Fisker Inc. (NYSE:FSR) jumped 5.3% to $9.63. Needham recently initiated coverage on the stock with a Buy rating and $12 price target.
  • Gogo Inc. (NASDAQ:GOGO) gained 5% to $12.84. Gogo agreed to repurchase 1,500,000 shares of common Stock owned by affiliates of BlackRock, Inc, in a private transaction.
  • ALaunos治療公司納斯達克(股票代碼：TCRT)股價在週四下跌38%後，大漲22.2%，至2.5788美元。
  • 鮑萊羅公司(紐約證券交易所股票代碼：Bowl)股價飆升8.1%，至13.48美元，此前該公司公佈第四季度銷售額好於預期。
  • 阿爾法頭醫療有限公司納斯達克(Tmall：DRTS)上漲8.1%，至6.03美元。
  • 和聲公司(納斯達克股票代碼：HLIT)上漲7.6%，至12.05美元。Needham維持Harmonic with a Buy，並將目標價從15美元上調至17美元。
  • AMTD Digital Inc.(紐約證券交易所代碼：HKD)股價上漲7.1%，至144.28美元，週四曾暴跌約29%。
  • Lucid Group公司納斯達克(Alipay：LCID：LCID)跳漲6.5%，報17.55美元。
  • 哈德遜技術公司納斯達克股價上漲6.4%，至8.04美元。上個月，該公司公佈了樂觀的季度業績。
  • Fisker Inc.(紐約證券交易所代碼：FSR)股價上漲5.3%，至9.63美元。李約瑟最近對該股進行了買入評級和12美元的目標價。
  • Gogo Inc.納斯達克(GOG.O：行情)上漲5%，報12.84美元。Gogo同意以非公開交易的方式回購貝萊德公司關聯公司持有的1500,000股普通股。
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論